Recent advances in the molecular pathophysiology of atrial fibrillation.
about
Prediction of atrial fibrillation development and progression: Current perspectivesCardiomyocyte Remodeling in Atrial Fibrillation and Hibernating Myocardium: Shared Pathophysiologic Traits Identify Novel Treatment Strategies?Ion Channels in the HeartCalcium dysregulation in atrial fibrillation: the role of CaMKIIAberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Atrial Fibrillation: The Science behind Its DefianceEfficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysisMicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillationImpact of ancestry and common genetic variants on QT interval in African Americans.EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: Definition, characterisation, and clinical implication.Translational research in atrial fibrillation: a quest for mechanistically based diagnosis and therapy.Expression and function of Kv1.1 potassium channels in human atria from patients with atrial fibrillation.Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.x, and Kir7.1.Computational mapping identifies localized mechanisms for ablation of atrial fibrillation.Lone atrial fibrillation: does it exist?Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial FibrillationEffects of low-intensity autonomic nerve stimulation on atrial electrophysiology.Impaired local regulation of ryanodine receptor type 2 by protein phosphatase 1 promotes atrial fibrillation.Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies.Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation.Pioglitazone improves potassium channel remodeling induced by angiotensin II in atrial myocytes.A Non-Surgeon's Guide to Surgical Management of Atrial Fibrillation.The expression levels of plasma micoRNAs in atrial fibrillation patients.Norepinephrine-Induced Adrenergic Activation Strikingly Increased the Atrial Fibrillation Duration through β1- and α1-Adrenergic Receptor-Mediated Signaling in Mice.Personalized medicine and atrial fibrillation: will it ever happen?Family history as a risk factor for recurrent hospitalization for lone atrial fibrillation: a nationwide family study in SwedenFibroblast electrical remodeling in heart failure and potential effects on atrial fibrillationImpact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)Atrial arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia--is there a mechanistic link between sarcoplasmic reticulum Ca(2+) leak and re-entry?Cellular and molecular mechanisms of atrial arrhythmogenesis in patients with paroxysmal atrial fibrillation.Atrial fibrillation-linked germline GJA5/connexin40 mutants showed an increased hemichannel functionThe involvement of TRPC3 channels in sinoatrial arrhythmiasLKB1 knockout mouse develops spontaneous atrial fibrillation and provides mechanistic insights into human disease process.Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013.Bioptic Study of Left and Right Atrial Interstitium in Cardiac Patients with and without Atrial Fibrillation: Interatrial but Not Rhythm-Based Differences.Influence of Zoledronic Acid on Atrial Electrophysiological Parameters and Electrocardiographic Measurements.Chronotropic Modulation of the Source-Sink Relationship of Sinoatrial-Atrial Impulse Conduction and Its Significance to Initiation of AF: A One-Dimensional Model Study.Cellular Hypertrophy and Increased Susceptibility to Spontaneous Calcium-Release of Rat Left Atrial Myocytes Due to Elevated Afterload.MicroRNAs as Biomarkers for Acute Atrial Remodeling in Marathon Runners (The miRathon Study--A Sub-Study of the Munich Marathon Study).
P2860
Q26750083-BF7A5B70-6ED6-43ED-888F-257D12281EE8Q26801890-577AB6D4-78A8-4701-8FDD-4006D3E6EF11Q26829681-5E81B272-DFF5-4BC7-B3CA-73E4E0A029B4Q27027326-EA75B207-13A6-43E4-ABED-68941C07D33AQ27329882-034B158B-56BB-41E8-9527-47E975B649F6Q27341873-823CCFE4-1322-4D7B-B1CC-3631FE07F861Q28072139-9F83FD01-C0CB-49A6-B9DF-427E526B5815Q28081598-BE519F2D-6759-4F10-A1B9-3F124654F02EQ28116103-C2265397-C3FB-4E0A-B830-6E42400A3FB1Q28709065-DDD307A6-1BC7-4093-9ED2-6C1C83D09E4BQ30375302-3F490649-88DC-4D10-9BBD-11FE548149F6Q30531060-92EFC197-ADFF-4520-9D8C-4FB2489DBFC3Q30828729-B59968AA-28DA-4AC3-966A-2DEEE88E5BE1Q31046406-4DAC516E-547D-4F82-8870-4F92E98E793BQ31103589-5C5E5A56-0CD0-4CCB-8975-B8CC8EC45A1EQ33560948-22EDC726-F58D-4393-B355-2CB094091657Q33820434-16E210E7-A029-4D93-8767-DAEE40E00600Q33984032-0AF855E4-3FFB-44A4-8542-2A6026B3256FQ34048290-1B43B95D-471C-4B15-86CA-1835B8C30435Q34109242-666388B0-A23E-4BA4-BDCF-1569DE669721Q34307746-DE3619A1-C488-4ED8-9E7D-839016BBAFA2Q34388593-449190E5-B94E-413E-A4BD-ACCF216015AEQ34398295-53DAA6BC-F27C-4F6F-B1CF-0317EAE4242DQ34427635-31F5CFFE-A6AD-4116-9021-334DF4651083Q34486523-EBEFDD3B-01D7-4F63-893C-E90CA98114B6Q34501117-9F777237-A6F6-4918-867C-975B5CE4A9D7Q34507611-37E8C8FA-3A47-4F90-AB73-0C77BEF6E884Q34561350-257FA3A8-B2F1-468D-A298-804CF98BFDD0Q34921180-5FCBD039-FF64-4EAA-943A-509F15469FF7Q35082640-E04B7456-7925-4EC5-867B-89C7EC911DA4Q35126445-B2D02BD9-1B1A-4829-AF95-D44D8D25AEAAQ35147842-8F1DECAF-56B3-4B83-9B9A-9DD28831BDCAQ35215931-22F27563-5F5D-413B-BF7D-B1E362076B5AQ35354278-239683D8-A2A9-427D-B1C0-E740FDE547E8Q35585789-312D7989-7EC8-4405-BE8D-415D39F37E71Q35661373-254CD88D-1F8A-442A-B5D4-6945C5007805Q35732066-745D2A3A-F08E-4A87-ADC4-3D1E684DE488Q35851594-87FF85D9-14D5-43F5-AD61-A8E0E6FF4E7CQ35880589-742A68D1-1B73-4315-8596-0D9AF5017C51Q35918422-12530EA2-FC02-4CAC-800F-554BB7475C00
P2860
Recent advances in the molecular pathophysiology of atrial fibrillation.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Recent advances in the molecular pathophysiology of atrial fibrillation.
@ast
Recent advances in the molecular pathophysiology of atrial fibrillation.
@en
type
label
Recent advances in the molecular pathophysiology of atrial fibrillation.
@ast
Recent advances in the molecular pathophysiology of atrial fibrillation.
@en
prefLabel
Recent advances in the molecular pathophysiology of atrial fibrillation.
@ast
Recent advances in the molecular pathophysiology of atrial fibrillation.
@en
P2093
P2860
P356
P1476
Recent advances in the molecular pathophysiology of atrial fibrillation
@en
P2093
Dobromir Dobrev
Niels Voigt
Reza Wakili
Stefan Kääb
P2860
P304
P356
10.1172/JCI46315
P407
P577
2011-08-01T00:00:00Z